Panacea Acquisition Corp. II (PANA) News
Filter PANA News Items
PANA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest PANA News From Around the Web
Below are the latest news stories about Panacea Acquisition Corp II that investors may wish to consider to help them evaluate PANA as an investment opportunity.
Top 9 Stock Picks of Jacob Rothschild’s RIT Capital PartnersIn this article, we discuss the top 9 stock picks of Jacob Rothschild’s RIT Capital Partners. If you want to skip our detailed analysis of these stocks, go directly to the Top 4 Stock Picks of Jacob Rothschild’s RIT Capital Partners. Jacob Rothschild started his career at N. M. Rothschild & Sons in 1959. In […] |
Panacea Acquisition Corp. II Announces Pricing of $150,000,000 Initial Public OfferingSAN FRANCISCO, CA, April 06, 2021 (GLOBE NEWSWIRE) -- Panacea Acquisition Corp. II (the “Company”), a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, today announced the pricing of its initial public offering of 15,000,000 Class A ordinary shares at a price of $10.00 per share. The Company is sponsored by EcoR1 Panacea Holdings II, LLC, an affiliate of EcoR1 Capital, LLC. While the Company may pursue an initial business combination target in any industry or geographic location, it intends to focus its search for a target business operating in the biotechnology sector that is domiciled in North America or Europe. The Class A ordinary shares are ... |